sur Zeto
Zeto Announces Expert Jury for Its EEG Clinical Trial Sponsorship Program
Zeto, Inc., an EEG brain monitoring company, has introduced the members of its jury panel for a new clinical trial sponsorship program. This panel consists of notable experts from neurology and neuroscience fields. It includes Robert Fisher, MD, PhD, Director of the Stanford Epilepsy Center and Michael Weisend, PhD, known for his work in cognitive neuroscience.
The jury will assess clinical trials that aim to improve biomedical research and patient care using innovative EEG applications. They will focus on projects aligning with Zeto's vision and expected to have significant patient care impacts. The selection of clinical trials will complete by June 1st, 2024, with an announcement expected by June 10th, 2024.
R. E.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Zeto